Rankings
▼
Calendar
PRCT Q4 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena
PRCT
PROCEPT BioRobotics Corporation
$1B
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$68M
+56.6% YoY
Gross Profit
$44M
64.0% margin
Operating Income
-$20M
-28.9% margin
Net Income
-$19M
-27.6% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+16.9%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$34M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$534M
Total Liabilities
$132M
Stockholders' Equity
$402M
Cash & Equivalents
$334M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$68M
$44M
+56.6%
Gross Profit
$44M
$21M
+105.5%
Operating Income
-$20M
-$30M
+33.3%
Net Income
-$19M
-$28M
+31.4%
Geographic Segments
UNITED STATES
$60M
88%
Outside the United States
$8M
12%
← FY 2024
All Quarters
Q1 2025 →